Collegium Pharmaceutical Inc.

S&P 500

COLL/Healthcare · Drug Manufacturers - Specialty & Generic/NASDAQ

Stock Price

$34.84

Stock Price$34.84P/E16.3MCap1.1BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

COLL does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Collegium Pharmaceutical Inc.

Collegium Pharmaceutical is a specialty biopharmaceutical company focused on developing and commercializing medicines for pain management and neuropsychiatric conditions. The company's primary portfolio includes Jornay PM, a central nervous system stimulant for attention deficit hyperactivity disorder; Belbuca, a buccal film containing buprenorphine for chronic pain; and Xtampza ER, an abuse-deterrent extended-release oral formulation of oxycodone. Collegium also offers Nucynta products in extended-release and immediate-release formulations, along with Symproic for opioid-induced constipation. The company employs proprietary DETERx platform technology designed to maintain safety profiles while deterring abuse through various manipulation methods. Headquartered in Stoughton, Massachusetts, and founded in 2002, Collegium serves healthcare providers and patients across the United States, positioning itself as a leader in responsible pain management and ADHD treatment.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

—

FCF Payout Ratio

0.00%

52-Week Range

$29.19 - $50.79

Earnings & Profitability

COLL earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

COLL Dividend Calculator

Number of Shares

Total Investment

$3,484.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is COLL's current dividend yield?

Collegium Pharmaceutical Inc. (COLL) currently has a dividend yield of 0.00%, based on a stock price of $34.84 and an annual dividend of $0.00.

When is COLL's next dividend payment date?

COLL's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does COLL pay in dividends per year?

Collegium Pharmaceutical Inc. pays dividends unknown. Annual dividend data is not yet available.

Has COLL been increasing its dividend?

Collegium Pharmaceutical Inc. has grown its dividend at a 5-year CAGR of —.

Is COLL's dividend safe?

Collegium Pharmaceutical Inc. has a payout ratio of —. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is COLL's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Collegium Pharmaceutical Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track COLL Dividends with OnlyDividends

What will COLL actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.